Study about use of local anaesthetic in spinal anaesthesia for postoperative pain management

A Comparative study of Levobupivacaine and Levobupivacaine with Dexmedetomidine in lower abdominal , lower limb surgeries under spinal anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057355

Enrollment

Registered

2023-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: LEVOBUPIVACAINE: Inj.Levobupivacaine(hyperbaric)0.5% 3ml(15mg) intrathecal administration. Control Intervention2: LEVOBUPIVACAINE with DEXMEDETOMIDINE: Inj.Levobupivacaine(hyper

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA class I II and III 2.Age 18-70yrs 3.Patients undergoing lower abdominal ,lower limb surgeries 4.BMI more than 30 5.Patient who has given valid informed consent

Exclusion criteria

Exclusion criteria: Patients with known allergy to test drug 1.Patients with gross spinal deformities 2.Patient posted with bleeding diathesis 3.Patients with a history of any cardiac or respiratory or CNS disease. 4.Patients with hepatic or renal dysfunction, 5.Patients with raised intra cranial pressure. 6.Pregnant females. 7.Chronic alcoholic patients and malnourished patients

Design outcomes

Primary

Measure	Time frame
To compare the time of sensory blockade & height of motor ans sensory blockade as per Bromage scale & total duration of sensory blockade & motor blockadeTimepoint: Sampling Time per Min S0S1S2S5S10S25S30SR	—

Secondary

Measure	Time frame
To compare efficacy of Levobupivacaine & Levobupivacaine with Dexmedetomidine using visual analogue score(VAS).Timepoint: VAS P10 P20 P30 P2hrs P6hrs	—

Countries

India

Contacts

Public ContactDr Balakrishnan R

Sri Siddartha medical college and hospital

dr.sujay79@yahoo.com9008492882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026